文献速递重症综合管理与镇静镇痛心脑血管急症

急性脑损伤危重成人选择性消化道去污染:一项随机临床试验的事后分析

Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial.
PubMed 文献 · Intensive Care Med · 2023-11-20
一句话结论在机械通气的急性脑损伤危重成人中,选择性消化道去污染(SDD)较标准治疗降低住院死亡率(32.3% vs 38%,未校正OR 0.76,95%CI 0.63-0.92;p=0.004),但作者指出这些发现需进一步确认。

该研究为交叉、整群随机临床试验的事后分析,纳入ICU机械通气的急性脑损伤成人2061例(平均年龄55.8岁,女性36.4%)。SDD组(n=2791,其中急性脑损伤968例)接受含多黏菌素、妥布霉素和制霉菌素的口腔糊剂每6小时一次及胃内混悬液,持续整个机械通气期间,并加用4天静脉抗生素;对照组(n=3191,其中急性脑损伤1093例)接受标准治疗。急性脑损伤患者中,SDD组住院死亡313/968(32.3%),标准治疗组415/1093(38%),未校正OR 0.76(95%CI 0.63-0.92;p=0.004);SDD还使四项次要临床结局有统计学显著改善;有无急性脑损伤患者间治疗效应无显著异质性(交互p=0.22)。作者结论认为SDD显著降低住院死亡率,但这些发现需进一步确认。

要点

  • 急性脑损伤机械通气患者中,SDD组住院死亡32.3%(313/968)vs 标准治疗组38%(415/1093),未校正OR 0.76(95%CI 0.63-0.92;p=0.004)。
  • SDD方案为口腔糊剂及胃内混悬液(含多黏菌素、妥布霉素、制霉菌素)每6小时一次,持续机械通气期间,并加用4天静脉抗生素。
  • SDD使四项次要临床结局(ICU死亡、无呼吸机日、无ICU日、无住院日至第90天)较标准治疗有统计学显著改善。
  • 有无急性脑损伤患者间治疗效应无显著异质性(交互p=0.22)。
  • 作者结论认为SDD显著降低住院死亡率,但这些发现需进一步确认。

适用人群与场景

  • ICU收治的机械通气危重成人,且因急性脑损伤或脑部疾病入院(急性脑损伤患者共2061例,平均年龄55.8岁,女性36.4%)。
  • SDD组共2791例(其中急性脑损伤968例),对照组共3191例(其中急性脑损伤1093例)。

处置流程与药物剂量

  • SDD组:口腔糊剂及胃内混悬液(含多黏菌素、妥布霉素、制霉菌素)每6小时一次,持续整个机械通气期间,并加用4天静脉抗生素(抗菌谱适宜)。
  • 对照组:接受标准治疗(未采用SDD策略)。

研究设计与关键结果

  • 研究类型:交叉、整群随机临床试验的事后分析;ICU被随机分配在兩個交替的12个月期间采用或不采用SDD策略,期间间隔3个月。
  • 急性脑损伤患者中,SDD组住院死亡313/968(32.3%),标准治疗组415/1093(38%),未校正OR 0.76(95%CI 0.63-0.92;p=0.004)。
  • SDD较标准治疗使四项次要临床结局(ICU死亡、无呼吸机日、无ICU日、无住院日至第90天)有统计学显著改善。
  • 有无急性脑损伤患者间治疗效应无显著异质性(交互p=0.22)。
  • 2061例急性脑损伤患者均完成试验。

证据类型、等级与局限

  • 证据类型:随机临床试验的事后分析。
  • 作者结论:SDD显著降低住院死亡率,但这些发现需进一步确认。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在机械通气的急性脑损伤ICU患者中,SDD策略(口腔糊剂及胃内混悬液每6小时一次,持续机械通气期间,加用4天静脉抗生素)与标准治疗相比降低住院死亡率(32.3% vs 38%,未校正OR 0.76,95%CI 0.63-0.92;p=0.004)。
  • 作者认为这些发现需进一步确认。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to determine whether selective decontamination of the digestive tract (SDD) reduces in-hospital mortality in mechanically ventilated critically ill adults admitted to the intensive care unit (ICU) with acute brain injuries or conditions.

METHODS: We carried out a post hoc analysis from a crossover, cluster randomized clinical trial. ICUs were randomly assigned to adopt or not to adopt a SDD strategy for two alternating 12-month periods, separated by a 3-month inter-period gap. Patients in the SDD group (n = 2791; 968 admitted to the ICU with an acute brain injury) received a 6-hourly application of an oral paste and administration of a gastric suspension containing colistin, tobramycin, and nystatin for the duration of mechanical ventilation, plus a 4-day course of an intravenous antibiotic with a suitable antimicrobial spectrum. Patients in the control group (n = 3191; 1093 admitted to the ICU with an acute brain injury) received standard care. The primary outcome was in-hospital mortality within 90 days. There were four secondary clinical outcomes: death in ICU, ventilator-, ICU- and hospital-free days to day 90.

RESULTS: Of 2061 patients with acute brain injuries (mean age, 55.8 years; 36.4% women), all completed the trial. In patients with acute brain injuries, there were 313/968 (32.3%) and 415/1093 (38%) in-hospital deaths in the SDD and standard care groups (unadjusted odds ratio [OR], 0.76, 95% confidence interval [CI] 0.63-0.92; p = 0.004). The use of SDD was associated with statistically significant improvements in the four clinical secondary outcomes compared to standard care. There was no significant heterogeneity of treatment effect between patients with and without acute brain injuries (interaction p = 0.22).

CONCLUSIONS: In this post hoc analysis of a randomized clinical trial in critically ill patients with acute brain injuries receiving mechanical ventilation, the use of SDD significantly reduced in-hospital mortality in patients compared to standard care without SDD. These findings require confirmation.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Young PJ, Devaux A, Li Q, et al. Selective digestive tract decontamination in critically ill adults with acute brain injuries: a post hoc analysis of a randomized clinical trial. Intensive Care Med. 2023. PMID: 37982826. doi:10.1007/s00134-023-07261-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。